眼科藥物市場：依適應症、類型、劑型、通路、治療分類及地區分類。

Ophthalmic Drugs Market, By Indication, By Type, By Dosage Form, By Distribution Channel, By Therapeutic Class, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，眼科藥品市場規模將達到569.2億美元，到2033年將達到846.9億美元。預計從2026年到2033年，該市場將以5.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	569.2億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	5.80%	2033年市場規模預測：	846.9億美元

眼科學是醫學的一個分支，專注於眼睛的健康。它包括眼睛的解剖結構、生理功能以及可能影響眼睛的疾病。同時，眼科藥物用於治療各種眼部疾病，例如白內障、青光眼、感染疾病、過敏、發炎、視網膜疾病（濕性老齡化黃斑部病變、乾性老齡化黃斑部病變、糖尿病視網膜病變等）以及其他眼部疾病。

市場動態

眼科疾病盛行率上升、人口老化、對安全有效的眼科藥物的需求不斷成長、對眼科藥物研發的日益重視以及研發的不斷擴大，預計這些因素將推動全球眼科藥物市場在預測期內成長。

例如，2022年4月，山德士宣佈在美國推出其非專利複方眼藥水－酒石酸溴莫尼定/馬來酸Maleate0.2%/0.5%（艾伯維公司COMBIGAN的AB類仿製非專利），用於降低眼高壓患者的眼內壓。此外，2022年3月，Thea Pharma從Akorn Operating Company LLC收購了七個眼科產品品牌，進一步鞏固了其作為美國眼科醫生所需產品的領先供應商的地位。

本研究的關鍵特徵

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數，對全球眼科藥品市場的主要參與者進行了分析。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球眼科藥品市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
相關人員可以透過分析全球眼科藥品市場中使用的各種策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 56.92 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 84.69 Bn

Ophthalmology is a specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology, and diseases that may affect the eye. Whereas, ophthalmic drugs are used to treat various disorders associated with the eyes, such as cataracts, glaucoma, infection, allergy, and inflammation, retinal disorders (such as wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others), and other ophthalmic disorders.

Market Dynamics

Rise in prevalence of ophthalmic disorders, growing geriatric population, rise in demand for safe and effective ophthalmic drugs, rise in focus on the development of ophthalmic drugs, and increase in research and development are major factors expected to propel growth of the global ophthalmic drugs market during the forecast period.

For instance, in April 2022, Sandoz announced the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, AB-rated generic equivalent to AbbVie's COMBIGAN, to lower eye pressure in patients with ocular hypertension. Moreover, in March 2022, Thea Pharma acquired seven branded ophthalmic products from Akorn Operating Company LLC to strengthen its position as a significant provider of products developed to satisfy the demands of eye care specialists across the United States.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global ophthalmic drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG, Pfizer Inc., Bausch & Lomb Incorporated, F. Hoffmann-LA Roche Ltd. (Genentech, Inc.), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global ophthalmic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ophthalmic drugs market.

Market Segmentation

Global Ophthalmic Drugs Market, By Indication (Revenue, USD Bn, 2021 - 2033)
Dry Eye
Glaucoma
Infection/Inflammation/Allergy
- Retinal Disorder
- Wet Age-related Macular Degeneration
- Dry Age-related Macular Degeneration
- Diabetic Retinopathy
- Others
Others
Global Ophthalmic Drugs Market, By Type (Revenue, USD Bn, 2021 - 2033)
Prescription Drugs
Over-the-counter Drugs
Global Ophthalmic Drugs Market, By Dosage Form (Revenue, USD Bn, 2021 - 2033)
Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
Other Ophthalmic Drug Forms
Global Ophthalmic Drugs Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Drug Stores
Online Pharmacies
Others
Global Ophthalmic Drugs Market, By Therapeutic Class (Revenue, USD Bn, 2021 - 2033)
Anti-glaucoma
Anti-infection
Anti-inflammation
Anti-allergy
Others
Global Ophthalmic Drugs Market, By Geography (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Global Ophthalmic Drugs Market: Key Companies Insights
Abbvie Inc. (Allergan Plc)
Alcon, Inc.
Novartis AG
Pfizer Inc.
Bausch & Lomb Incorporated
Hoffmann-LA Roche Ltd. (Genentech, Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Therapeutic Class
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of ophthalmic disorders
- Risks associated with ophthalmic drugs
- High demand for safe/effective ophthalmic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Ophthalmic Drugs Market, By Indication, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dry Eye
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Infection/Inflammation/Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Retinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  - Wet Age-related Macular Degeneration
  - Dry Age-related Macular Degeneration
  - Diabetic Retinopathy
  - Others
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Ophthalmic Drugs Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Over-the-counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Ophthalmic Drugs Market, By Dosage Form, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Liquid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Solid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Semisolid Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Multicompartment Drug Delivery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Other Ophthalmic Drug Forms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

7. Global Ophthalmic Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

8. Global Ophthalmic Drugs Market, By Therapeutic Class, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Anti-infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Anti-inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Anti-allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

9. Global Ophthalmic Drugs Market, By Geography, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Class, 2021 - 2033,(USD Bn)

10. Competitive Landscape

Abbvie Inc. (Allergan Plc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alcon, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bausch & Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-LA Roche Ltd. (Genentech, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views